Hukelmann, Jens L.
Immatics Biotechnologies (Germany)
5 papers on CoChatORCID 0000-0001-8360-9062
Most cited papers
- Verified
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells
Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine
PI3K/AKT/mTOR signaling in cancerT-cell and B-cell Immunology
Cited by 596
- Verified
The cytotoxic T cell proteome and its shaping by the kinase mTOR
Hukelmann, J. L., Anderson, K. E., Sinclair, L. V., Grzes, K. M., Murillo, A. B., Hawkins, P. T., Stephens, L. R., Lamond, A. I., & Cantrell, D. A. (2016) · Nature Immunology
PI3K/AKT/mTOR signaling in cancerT-cell and B-cell Immunology
Cited by 249
- Verified
Quantitative analysis of T cell proteomes and environmental sensors during T cell differentiation
Howden, A. J. M., Hukelmann, J. L., Brenes, A., Spinelli, L., Sinclair, L. V., Lamond, A. I., & Cantrell, D. A. (2019) · Nature Immunology
T-cell and B-cell ImmunologyAdvanced Proteomics Techniques and Applications
Cited by 231
- Verified
Multibatch TMT reveals false positives, batch effects and missing values
Brenes, A., Hukelmann, J., Bensaddek, D., & Lamond, A. I. (2019) · Molecular & Cellular Proteomics
Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and Applications
Cited by 196
- Verified
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
Wermke, M., Araujo, D. M., Chatterjee, M., Tsimberidou, A. M., Holderried, T. A. W., Jazaeri, A. A., Reshef, R., Bokemeyer, C., Alsdorf, W., Wetzko, K., et al. (2025) · Nature Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 73
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free